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ABSTRACT
Background. To identify the factors associated with lower urinary tract symptoms
(LUTS), we investigated associations between psychological factors, including de-
pression and sleep disorders, and LUTS using the National Health and Nutrition
Examination Survey (NHANES) database.
Materials andMethods. The NHANES database was examined for the period of 2005
to 2008. Men older than 40 years, who had completed questionnaires surveying their
kidney/urologic, prostate, mental health, and sleep conditions were included in this
study. LUTS was defined as the presence of two or more of the following symptoms:
incomplete emptying, urinary hesitancy, urinary frequency, and nocturia.Multivariable
models using logistic regression were used to compare groups of men with or without
LUTS.
Results. Of 1,820 participants, 110 (6.1%) men reported depression, and 235 (12.9%)
presented with LUTS. Men with LUTS were older and had a significantly higher
prevalence of depression and unemployment. Sleep disorder was not associated with
LUTS. Multivariable logistic regression models demonstrated that men reporting
moderate depression had the highest age-adjusted odds (odds ratio = 5.89, 95% CI
[3.44–10.11]; p< 0.001) of reporting clinical LUTS.
Conclusions. A significant association was observed between LUTS and depression,
and between LUTS and employment status. Although the pathophysiology of these
relationships is unclear, physicians should consider multi-disciplinary evaluation and
treatment approaches for LUTS.
Subjects Psychiatry and Psychology, Urology
Keywords Lower urinary tract symptoms, Depression, NHANES
INTRODUCTION
Lower urinary tract symptoms (LUTS) are common in aging men, with approximately
80.0% of men experiencing at least one urinary symptom by the age of 80 (Wei, Calhoun &
Jacobsen, 2005). Treatment of LUTS is a substantial financial burden on the United States
healthcare system (Hu et al., 2004). Moreover, LUTS has been found to have a significant
negative impact on quality of life in several studies (Coyne et al., 2009; Robertson et al.,
2007). Although LUTS is highly prevalent, poses an economic burden, and adversely
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affects quality of life, few treatment modalities for it exist, and although pharmacologic
interventions are considered first-line therapy, Cindolo et al. (2015) reported that only
29.0% of patients use these drugs for 1 year, indicating that adherence to these medications
is poor.
Most medications for LUTS focus on solving bladder outlet obstruction resulting from
hypertrophy of the prostate.However, there aremultifactorial causes of LUTS development,
and the often reported ineffectiveness of pharmacologic therapies implies that the cause
of LUTS is not always prostate-centric (Kakizaki & Koyanagi, 2000). Indeed, a variety of
factors have been reported to be associated with the development and progression of LUTS,
including age-dependent structural and functional changes in the bladder and urethra,
neurological and hormonal changes, diabetes and obesity, psychological and behavioral
changes, and alterations in sleep patterns (Kakizaki & Koyanagi, 2000;Helf et al., 2011;Helf
et al., 2012; Tam, Helfand & Erickson, 2017).
Several studies have reported on associations between psychological factors and LUTS.
Most studies have focused on depression, which has been widely reported to be associated
with LUTS (Coyne et al., 2009; Hakkinen et al., 2008; Laumann et al., 2008; Steers, Litman
& Rosen, 2008; Fitzgerald et al., 2007). A few have reported an association between sleep
disorders and the development of nocturia. A recent study reported a relationship between
sleep disorders and LUTS (Fantus et al., 2018).
To our knowledge, this is the first study to thoroughly investigate factors associated
with LUTS from the National Health and Nutrition Examination Survey (NHANES),
2007–2008, which is a large, cross-sectional dataset that is representative of the United
States population.We investigated demographic differences and psychological factors, such
as depression and sleep disorders, in patients with LUTS in order to identify dominant
factors associated with LUTS.
MATERIALS & METHODS
Data source
The NHANES is a cross-sectional observational study that collects health-related
information using a complex, stratified,multistage, probability cluster design representative
of the general non-institutionalized United States population. The Institutional Review
Board of theNational Center forHealth Statistics approved the protocol, and all participants
provided written informed consent to the National Center for Health Statistics. This
study included datasets for 2005–2006 and 2007–2008, as only these datasets contained
information related to both urinary symptoms and psychological factors including
depression and sleep disorders.
Study population
We included men aged 40 years or older who completed questionnaires surveying the
following: kidney/urologic conditions, prostate conditions, mental health conditions, and
sleep conditions. We excluded all men with prostate disease, including prostate cancer
(15,839 patients), men with stroke who had comorbidities associated with neurogenic
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bladder (127 patients), and those with missing data (2,019 patients), leaving 1,820 eligible
participants.
LUTS
Several questions were used to assess LUTS including the following: (1) After urinating,
does your bladder feel empty? (responses: yes/no, incomplete emptying); (2) Do you
usually have trouble starting to urinate? (yes/no, hesitancy); (3) How often do you have
urinary leakage? (defined as not able to hold urine until reaching a toilet at least once
a month, urinary frequency); (4) How many times per night do you usually get up to
urinate? (defined as waking at least twice per night to urinate, nocturia). Daytime LUTS
was defined as the presence of more than one of the symptoms surveyed in questions 1–3.
Clinical LUTS was defined as the presence of any two or more of the surveyed symptoms
(questions 1–4).
Depression
Depression was measured using the Nine-item Patient Health Questionnaire (PHQ-9)
depression scale, a nine-item screener that asks questions about the frequency of symptoms
of depression scored from 0 to 27, and that is widely used in both clinical and research
settings (Kroenke & Spitzer, 2002). A PHQ-9 score of 10 or greater was used as a cutoff
for identifying major depression (sensitivity 88.0% and specificity 88.0%) (Kroenke &
Spitzer, 2002). Depression scores were categorized into four groups: minimal (<5), mild
(5–9), moderate to moderately severe (10–14), and moderately severe to severe (≥15). The
validity and reliability of PHQ and its nine-item depression module in depressive diagnosis
and grade of severity have been widely documented (Kroenke, Spitzer & Williams, 2001;
Kroenke et al., 2010; Spitzer, Kroenke & Williams, 1999; Spitzer et al., 2000).
Other measurements
All participants were asked about age, race/ethnicity (non-Hispanic white, non-Hispanic
black, Mexican American, or those who selected multiple races or other racial/ethnic
groups), educational attainment (less than a high school diploma, high school graduate, or
education beyond high school), household income (poverty income ratio [PIR], PIR <1, 1
≤PIR<3, or PIR≥3), married or living with a partner (yes or no), employment (yes or no),
health insurance status (yes or no), smoking status (current, former, or never), and binge
drinker (defined as having ever consumed ≥5 drinks of any kind of alcoholic beverage
almost every day; yes or no). A prior self-reported history of coronary artery disease (CAD),
congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), including
emphysema and/or chronic bronchitis, and malignancies were included.
Hypertension was defined as the use of antihypertensive medication or a reported
blood pressure of 140/90 mmHg or higher. Blood pressure was measured using a mercury
sphygmomanometer. Diabetes was defined as a self-reported previous diagnosis of the
disease by a healthcare provider or a hemoglobin A1c level of 6.5% or greater (the diagnostic
criterion for diabetes according to the American Diabetes Association 2010).
Height and weight were measured in a medical examination center, and body mass
index (BMI) was calculated as weight in kilograms divided by height in meters squared.
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Participants were divided into three BMI groups: normal weight or underweight (BMI
<25 kg/m2), overweight (BMI = 25 to <30 kg/m2), and obese (BMI ≥30 kg/m2).
A subject was considered to have a sleep disorder if they answered ‘‘yes’’ to the question
‘‘Have you been diagnosed as having a sleep disorder?’’
Statistical analysis
Data are reported as means ± standard deviations (SDs) for continuous variables and for
categorical variables, data are reported as percentages. Since the size of the study population
was large enough to represent the US population and the values were not skewed in clinical
perspective, t-tests were used to compare continuous variables, and chi-square test was used
to compare categorical variables in univariable analysis. Multivariable logistic regression
models were used for multivariable analysis, including all risk factors that were significant
in univariable analysis. Multicollinearity was measured using variance inflation factor
(VIF) for 12 independent variables used in multivariable logistic regression models and
VIFs were less than 2, showing that there was no problem with multicollinearity (DeMaris,
2004).
A model of multivariable logistic regression analysis was used to evaluate the association
between the severity of depression and LUTS (clinical LUTS, daytime LUTS, and individual
symptoms of incomplete bladder emptying, urinary hesitancy, urinary frequency, and
nocturia) after adjusting for potential confounding factors. We evaluated the odds ratios
(ORs) and 95% confidence intervals (CIs) of reporting clinical LUTS and individual
symptoms after adjusting for potential confounders in two models: first, we added age
and then we adjusted models for educational attainment, household income, employment,
binge drinking, smoking status, hypertension, diabetes, CAD, CHF, COPD, and cancer. As
LUTS is not common disease entity, we used ORs to estimate relative risks.
SPSS software, version 23.0 (SPSS Inc., Chicago, IL, USA) was used to conduct all




Baseline characteristics of the study population are shown in Table 1. The mean ±SD age
of the participants was 56.9± 11.8 years. Their mean±SD BMI was 28.9± 6.1 kg/m2, and
77.0% were included in the overweight or obese group. Overall, 30.0% of the participants
had an educational level of less than a high school diploma, and 58.8% were currently
working. Moreover, 25.1% were current smokers, and 27.4% were binge drinkers. The
prevalences of hypertension and diabetes were 49.5% and 14.2%, respectively. In the
2005–2008 sample, 6.1% of participants had depression (PHQ-9 score ≥10). Among
participants, 25.2% had daytime LUTS and 12.9% had clinical LUTS.
Factors associated with daytime LUTS
Men with daytime LUTS were significantly older and had higher prevalences of cigarette
smoking, hypertension, CAD, CHF, COPD, and depression, whereas their household
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Table 1 Characteristics of the study population.
Study population (n= 1,820)
Age (years) 56.9± 11.8
Race/ethnicity (%)
Non-Hispanic white 968 (53.2%)
Non-Hispanic black 352 (19.3%)
Mexican American 316 (17.4%)
Other 184 (10.1%)
Height (cm) 174.4± 7.6
Weight (kg) 88.2 ± 20.2
BMI (kg/m2) 28.9 ± 6.1
BMIa (%)
Normal weight or underweight 419 (23.0%)
Overweight 773 (42.5%)
Obese 628 (34.5%)
SBP (mmHg) 129.6± 18.8
DBP (mmHg) 73.9 ± 13.2
Education <High school (%) 546 (30.0%)
Household income, PIR (%)
PIR<1 289 (15.9%)
1 ≤PIR<3 713 (39.2%)
PIR ≥3 818 (44.9%)
Currently working (%) 1071 (58.8%)
Married or living with partner (%) 1325 (72.8%)
Insured (%) 1465 (80.5%)





Hypertensionc (%) 900 (49.5%)
Diabetesd (%) 259 (14.2%)
CAD (%) 133 (7.3%)
CHF (%) 82 (4.5%)
COPD (%) 144 (7.9%)
Cancer (%) 129 (7.1%)
Sleep disorder (%) 158 (8.7%)
Depression (%)
Mild (PHQ-9 Score of 5-9) 212 (11.6%)
Moderate (PHQ-9 Score of 10-14) 72 (4.0%)
Moderately Severe to Severe (PHQ-9 Score of ≥ 15) 38 (2.1%)
(continued on next page)
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Table 1 (continued)
Study population (n= 1,820)
Daytime LUTS (%) 459 (25.2%)
Clinical LUTS (%) 235 (12.9%)
Notes.
Data are presented as mean± SD for continuous variables and percentages for categorical variables.
SD standard deviation, BMI body mass index, CAD coronary artery disease, CHF congestive heart failure, COPD chronic obstructive pulmonary disease, DBP diastolic blood
pressure, SBP systolic blood pressure, PHQ-9 9-item patient health questionnaire, PIR poverty to income ratio, LUTS lower urinary tract symptoms.
aBMI was divided into three groups: normal weight or underweight (BMI< 25 kg/m2), overweight (BMI= 25 to< 30 kg/m2), and obese (BMI ≥30 kg/m2).
bDefined as having ever consumed five drinks or more of any kind of alcoholic beverage almost every day.
cDefined as use of antihypertensive medication or a reported blood pressure ≥140/90 mmHg.
dDefined as self-reported diabetes diagnosed by a health professional (all adults) or a hemoglobin A1c level ≥6.5%.
income and employment level were significantly lower than those of men without LUTS
(Table 2).
Factors associated with clinical LUTS
The characteristics of men with and without clinical LUTS were also compared (Table 2).
Age, household income, employment status, cigarette smoking, hypertension, CAD, CHF,
COPD, depression, educational attainment, binge drinking, diabetes, and cancer were
significantly associated with clinical LUTS in univariable analysis.
Association between PHQ-9 score and clinical LUTS
Logistic regression analyses were performed to examine the association between LUTS
and depression (Table 3). With clinical LUTS (two or more symptoms) as the outcome,
participants reportingmoderate to severe depression had the highest ORs of those reporting
LUTS. In the age-adjustedmodel,moderate to severe depressionwas significantly associated
with clinical LUTS (OR = 5.05, 95% CI [3.20–7.97]). Similar results were observed (OR
= 4.10, 95% CI [2.50–6.70]) in the multivariable adjusted model, which was adjusted
for factors that were significantly different between men with and without clinical LUTS.
When examining individual LUTS (incomplete emptying, urinary hesitancy, urinary
frequency, and nocturia), depression was associated with increased risk of each LUTS.
Participants with major depression (PHQ-9 score ≥10) were further divided into two
groups: (1)moderate depression and (2)moderately severe to severe depression. The logistic
regression model showed that the moderate depression group showed higher odds (OR =
5.89, 95% CI [3.44–10.11]) with clinical LUTS, and individual LUTSs, except incomplete
emptying, than the moderately severe to severe depression group (OR = 3.74, 95%
CI [1.75–8.00]).
DISCUSSION
In our study, daytime LUTS and clinical LUTS were significantly associated with age,
employment status, and depression. We also found that men with greater depression
scores were more likely to have LUTS, with the exception of those in the most severe
depression group. We modeled LUTS evaluated its association with severity of depression.
While treatment of LUTS in men has been mainly prostate-centric, our study suggests
that multiple factors might be involved in the development of LUTS and that this
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Table 2 Characteristics of the study population according to daytime and clinical LUTS.
Daytime LUTS Clinical LUTS
Daytime LUTS No Daytime LUTS Pe Clinical LUTS No Clinical LUTS Pe
(n= 459) (n= 1,361) (n= 235) (n= 1,585)
Age (years) 59.7± 12.1 55.9± 11.6 <0.001 61.9± 12.2 56.1± 11.6 <0.001
Race/ethnicity (%) 0.707 0.331
Non-Hispanic white 249 (54.2%) 719 (52.8%) 131 (55.7%) 837 (52.8%)
Non-Hispanic black 91 (19.8%) 261 (19.2%) 48 (20.4%) 304 (19.2%)
Mexican American 79 (17.2%) 237 (17.4%) 40 (17.0%) 276 (17.4%)
Other 40 (8.7%) 144 (10.6%) 16 (6.8%) 168 (10.6%)
Height (cm) 174.2± 7.6 174.5± 7.6 0.487 174.2± 7.4 174.4± 7.6 0.704
Weight (kg) 88.3± 23.7 88.2± 18.9 0.934 89.1± 21.3 88.1± 20.0 0.512
BMI (kg/m2) 29.0± 7.5 28.9± 5.5 0.646 29.3± 6.3 28.9± 6.0 0.393
BMI (%) 0.625 0.310
Normal weight or underweight 113 (24.6%) 306 (22.5%) 58 (24.7%) 361 (22.8%)
Overweight 189 (41.2%) 584 (42.9%) 89 (37.9%) 684 (43.2%)
Obese 157 (34.2%) 471 (34.6%) 88 (37.4%) 540 (34.1%)
SBP (mmHg) 130.5± 20.3 129.3± 18.2 0.275 132.0± 21.7 129.2± 18.3 0.062
DBP (mmHg) 73.3± 14.0 74.0± 13.0 0.323 73.1± 14.6 74.0± 13.0 0.365
Education <High school (%) 147 (32.0%) 399 (29.3%) 0.273 88 (37.4%) 458 (28.9%) 0.008
Household income, PIR (%) 0.023 <0.001
PIR<1 75 (16.3%) 214 (15.7%) 43 (18.3%) 246 (15.5%)
1 ≤PIR<3 202 (44.0%) 511 (37.5%) 114 (48.5%) 599 (37.8%)
PIR ≥3 182 (39.7%) 636 (46.7%) 78 (33.2%) 740 (46.7%)
Currently working (%) 242 (52.7%) 829 (60.9%) 0.002 95 (40.4%) 976 (61.6%) <0.001
Married or living with partner (%) 322 (70.2%) 1,003 (73.7%) 0.146 163 (69.4%) 1,162 (73.3%) 0.204
Insured (%) 377 (82.1%) 1,088 (79.9%) 0.305 194 (82.6%) 1,271 (80.2%) 0.393
Binge drinker (%) 137 (29.8%) 361 (26.5%) 0.167 78 (33.2%) 420 (26.5%) 0.032
Cigarette smoking (%) 0.027 0.001
Current 120 (26.1%) 336 (24.7%) 65 (27.7%) 391 (24.7%)
Past 186 (40.5%) 478 (35.1%) 106 (45.1%) 558 (35.2%)
Never 153 (33.3%) 547 (40.2%) 64 (27.2%) 636 (40.1%)
Hypertension (%) 257 (56.0%) 643 (47.2%) 0.001 143 (60.9%) 757 (47.8%) <0.001
Diabetes (%) 75 (16.3%) 184 (13.5%) 0.135 46 (19.6%) 213 (13.4%) 0.012
CAD (%) 46 (10.0%) 87 (6.4%) 0.010 26 (11.1%) 107 (6.8%) 0.018
CHF (%) 31 (6.8%) 51 (3.7%) 0.007 24 (10.2%) 58 (3.7%) <0.001
COPD (%) 53 (11.5%) 91 (6.7%) 0.001 31 (13.2%) 113 (7.1%) 0.001
Cancer (%) 41 (8.9%) 88 (6.5%) 0.075 29 (12.3%) 100 (6.3%) 0.001
Sleep disorder (%) 42 (9.2%) 116 (8.5%) 0.680 23 (9.8%) 135 (8.5%) 0.519







Daytime LUTS Clinical LUTS
Daytime LUTS NoDaytime LUTS Pe Clinical LUTS No Clinical LUTS Pe
(n= 459) (n= 1,361) (n= 235) (n= 1,585)
Depression (%) <0.001 <0.001
Mild (PHQ-9 Score of 5–9) 75 (16.3%) 137 (10.1%) 50 (21.3%) 162 (10.2%)
Moderate (PHQ-9 Score of 10–14) 36 (7.8%) 36 (2.6%) 24 (10.2%) 48 (3.0%)
Moderately Severe to Severe (PHQ-9 Score of ≥ 15) 15 (3.3%) 23 (1.7%) 10 (4.3%) 28 (1.8%)
Notes.
Data are presented as mean± SD for continuous variables and percentages for categorical variables.
BMI body mass index, CAD coronary artery disease, CHF congestive heart failure, CI confidence interval, COPD chronic obstructive pulmonary disease, DBP diastolic blood pressure, OR odds ratio, SBP
systolic blood pressure, PHQ-9 9-item patient health questionnaire, PIR poverty to income ratio, LUTS lower urinary tract symptoms.
aBMI was divided into three groups: normal weight or underweight (BMI<25 kg/m 2), overweight (BMI= 25 to<30 kg/m 2), and obese (BMI ≤30 kg/m 2).
bDefined as having ever consumed five drinks or more of any kind of alcoholic beverage almost every day.
cDefined as use of antihypertensive medication or a reported blood pressure ≥140/90 mmHg.
dDefined as self-reported diabetes diagnosed by a health professional (all adults) or a hemoglobin A1c level ≥6.5%.






Table 3 Association between the PHQ-9 score and LUTS.
PHQ-9 Categories





0–4 5–9 10–27 pb 10–14 15–27
(n= 1,498) (n= 212) (n= 110) (n= 72) (n= 38)
Clinical LUTS (2 or more symptoms):c 151 (10.1%) 50 (23.6%) 34 (30.9%) p < 0.001 24 (33.3%) 10 (26.3%)
Age adjusted OR (95% CI)d 1.00 3.27 (2.25–4.76) 5.05 (3.20–7.97) 5.89 (3.44–10.11) 3.74 (1.75–8.00)
Multivariate adjusted OR (95% CI)e 1.00 2.93 (1.99–4.30) 4.10 (2.50–6.70) 4.71 (2.67–8.32) 3.07 (1.39–6.81)
Daytime LUTS 333 (22.2%) 75 (35.4%) 51 (46.4%) p < 0.001 36 (50.0%) 15 (39.5%)
Age adjusted OR (95% CI)d 1.00 2.12 (1.55–2.89) 3.44 (2.30–5.14) 2.47 (1.26–4.82) 1.03 (1.02–1.04)
Multivariate adjusted OR (95% CI)e 1.00 2.11 (1.53–2.91) 3.41 (2.22–5.24) 3.95 (2.37–6.57) 2.54 (1.26–5.12)
Incomplete emptying: 119 (7.9%) 29 (13.7%) 18 (16.4%) p= 0.002 11 (15.3%) 7 (18.4%)
Age adjusted OR (95% CI)d 1.00 1.94 (1.25–3.00) 2.44 (1.41–4.19) 2.28 (1.16–4.46) 2.74 (1.18–6.37)
Multivariate adjusted OR (95% CI)e 1.00 1.76 (1.12–2.76) 1.92 (1.06–3.47) 1.75 (0.85–3.57) 2.28 (0.94–5.55)
Urinary hesitancy: 82 (5.5%) 23 (10.8%) 12 (10.9%) p= 0.003 9 (12.5%) 3 (7.9%)
Age adjusted OR (95% CI)d 1.00 2.32 (1.42–3.81) 2.43 (1.27–4.64) 2.91 (1.38–6.13) 1.62 (0.48–5.40)
Multivariate adjusted OR (95% CI)e 1.00 2.58 (1.55–4.30) 3.37 (1.67–6.79) 3.87 (1.75–8.55) 2.43 (0.70–8.45)
Urinary frequency: 183 (12.2%) 40 (18.9%) 33 (30.0%) p < 0.001 23 (31.9%) 10(26.3%)
Age adjusted OR (95% CI)d 1.00 1.83 (1.25–2.68) 3.49 (2.24–5.44) 3.92 (2.31–6.65) 2.78 (1.32–5.86)
Multivariate adjusted OR (95% CI)e 1.00 1.85 (1.25–2.74) 3.50 (2.16–5.69) 3.81 (2.17–6.68) 2.94 (1.33–6.51)
Nocturia: 403 (26.9%) 98 (46.2%) 55 (50.0%) p < 0.001 37 (51.4%) 18 (47.4%)
Age adjusted OR (95% CI)d 1.00 2.94 (2.15–4.02) 3.55 (2.36–5.34) 3.93 (2.39–6.46) 2.93 (1.50–5.72)
Multivariate adjusted OR (95% CI)e 1.00 2.64 (1.91–3.65) 2.84 (1.84–4.41) 3.18 (1.89–5.36) 2.29 (1.14–4.62)
Notes.
CI confidence interval, OR odds ratio, LUTS lower urinary tract symptoms, PHQ-9 9-item Patient Health Questionnaire.
aModerate to severe group for which a PHQ-9 score ≥10 was defined as the major depression group.
bDifferences of prevalence of LUTS between minimal, mild, and moderate to severe group was analyzed using the chi-square test.
bReported as at least 2 of 4 LUTS (incomplete bladder emptying, trouble starting to urinate, urinary frequency, and nocturia defined as 2 or more voids per night). This analysis
included only those men with no clinical LUTS or 2 or more LUTS reported.
cAdjusted for age in years.
dAdjusted for age in years, educational attainment, household income, employment, binge drinking, smoking status, hypertension, diabetes, coronary artery disease, congestive
heart failure, chronic obstructive pulmonary disease, and cancer.
urologic manifestation could be considered a socioeconomic and systemic disease with
psychological etiologies. We are planning future studies to determine whether reducing
levels of depression by medication would help symptoms of LUTS. This future study would
highlight the role of psychological treatment in LUTS if depression exists.
An association between depression and LUTS has been reported in several cross-
sectional studies (Coyne et al., 2009; Fitzgerald et al., 2007; Asplund et al., 2004; Wong
et al., 2010). Furthermore, a prospective study by Hakkinen et al. (2008) reported that
depressive symptoms increase the incidence of nocturia. This relationship can be explained
psychologically. LUTS reduces quality of life (Coyne et al., 2009; Robertson et al., 2007)
and can result in embarrassment, social anxiety, and demoralization (Breyer et al., 2014).
Indeed, men with LUTS report decreased self-esteem since they perceive it as a weakness
and part of the aging process (Wong et al., 2010). Nocturia may cause daytime drowsiness
and decrease concentration and activity levels, all of which could lead to an increased risk
for the development and progression of depression.
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Several molecular pathogeneses of an association between depression and LUTS have
been proposed. Steers et al. postulated that a defect in serotonin synthesis is associated with
the development of depression and abnormal voiding dysfunction. Increased adrenergic
tone and the hypothalamic-pituitary axis have been proposed as a mediator of depression
in LUTS (Laumann et al., 2008; Steers, Litman & Rosen, 2008). Furthermore, Klausner
& Steers (2004) suggested that stress-induced depression activates the corticotropin-
releasing factor pathway, which functions as a mediator of emotional influences on bladder
function.Moreover, inflammation represents a commonmechanism in the pathogenesis of
major depression and LUTS (Miller, Maletic & Raison, 2009; Johnson et al., 2010). Patients
with depression frequently exhibit increased levels of C-reactive protein, tumor necrosis
factor-alpha, and interleukin-6 (Miller, Maletic & Raison, 2009). Our results showed that
depressed patients (PHQ-9 score ≥ 10) had higher levels of C-reactive protein (0.62 ±
1.23 mg/dL) than those without (0.40 ± 0.77 mg/dL); however, the difference was not
statistically significant.
Contrary to a previous study that reported that men with greater depression scores
were more likely to have LUTS (Breyer et al., 2014), our results showed that patients with
the greatest depression scores were less likely to have LUTS than those with moderate
depression. Breyer et al. (2014) defined the depression group as those with a PHQ-9 score
≥10. In our study, we further divided the depression group into a moderate group and a
moderately severe to severe group. The moderate depression group showed higher odds
with clinical LUTS (OR = 5.89, 95% CI [3.44–10.11]) and individual symptoms of LUTS,
except incomplete emptying, compared to the moderately severe to severe depression
group (OR = 3.74, 95% CI [1.75–8.00]). This implies that clinical LUTS may not be
proportionally associated with the severity of depression. Although its pathogenesis is
unclear, the aforementioned molecular pathogenesis might not be feasibly true since if
molecular pathways are involved in mediating depression and LUTS, both severity levels of
depression and LUTS should be proportionally elevated. This finding implies the existence
of unaccounted pathogeneses that mediates LUTS.
Our results showed that there was no significant association between sleep disorders
and daytime or clinical LUTS. However, a recent study reported that men with sleep
disorders are significantly more likely to report both nocturia and daytime LUTS (Fantus
et al., 2018). Sleep disorders increase the risk of daytime urinary symptoms including
voiding and storage symptoms (Helf et al., 2011), whereas the improvement of LUTS
has been associated with an improvement in sleep disorders (Helf et al., 2012). Although
the proportion of men with sleep disorders was higher in the group with daytime and
clinical LUTS, the sleep disorder itself might not be a factor associated with LUTS, rather
a secondary feature of LUTS.
A cross-sectional study in six European countries reported that men with overactive
bladder symptoms were more likely than women to report that overactive bladder
symptoms had an impact on their daily work life (Irwin et al., 2006). Over 21.0% of
the study population reported being worried about an interruption of meetings owing to
urinary frequency, and 3.0% of the population changed or quit their jobs due to bladder
control problems. This study reported a negative association of LUTS on employment
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issues, which is similar to our results. To our knowledge, our study is the first to report a
negative association for LUTS on employment in a United States population.
This study has several limitations. First, due to the limitations of its cross-sectional
design, a causal relationship could not be established. Second, measurement of the severity
of LUTS was limited due to the lack of data of the International Prostate Symptom Score
(IPSS). A comparison between the IPSS and PHQ-9 score may have providedmore detailed
information regarding the association between LUTS and depression. Third, medical
conditions were assessed based on self-reporting. Therefore, some of the information for
the comorbid conditions might not be accurate. Fourth, treatments for the depression and
sleep disorders were not documented. Fifth, due to the retrospective analysis, the adequacy
of the sample size could not be checked. Sixth, we did not consider sampling weights since
our purpose was to study relations in a large community sample, rather than estimate
national prevalence rates. Therefore, we did not use sampling weights in our calculations
(Farmer et al., 1988). Seventh, we considered that the size of the study population was
large enough to represent the US population and the values were not skewed in clinical
perspective; therefore, we used geometric means and SDs and t-tests in univariable analysis.
Finally, voiding diaries were not included in the NHANES datasets, which deferred the
differential diagnosis of nocturnal polyuria and other causes of nocturia.
CONCLUSIONS
Our study revealed significant associations for depression and employment statuswith
clinical and daytime LUTS. The cause of LUTS is multifactorial, and psychological factors
seem to be significantly associated therewith. Therefore, patients presenting with LUTS
should be screened for multi-factorial etiologies using a psychological evaluation for a
successful multidisciplinary treatment approach.
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